FCRI gained 9% last month, while pharmas gained 6%, biotechs gained 7%, and the general market gained 7%. Seven FCRI stocks gained and two declined. Significant gainers included Syneos Health (+24%), Medpace Holdings (+21%), IQVIA (+18%), Hangzhou Tigermed Consulting Co Ltd (+16%), and PPRA Health Sciences (+14%). There were no significant decliners.
With courtesy of – www.magiworld.org
First Clinical Research Stock Index (FCRI) [Download]